2009
DOI: 10.1080/09540100903019400
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of olaquindox metabolite, methyl-3-quinoxaline-2-carboxylic acid for development of an immunoassay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 10 publications
0
10
0
Order By: Relevance
“…Its sensitivity, measurement range, and stability are substantially superior to those of the existing enzyme-linked immunosorbent assay (ELISA, L. L. Cheng et al 2013;Yue et al 2009). …”
Section: Introductionmentioning
confidence: 95%
“…Its sensitivity, measurement range, and stability are substantially superior to those of the existing enzyme-linked immunosorbent assay (ELISA, L. L. Cheng et al 2013;Yue et al 2009). …”
Section: Introductionmentioning
confidence: 95%
“…30 Hapten 4 was prepared by a similar method to that of hapten 3, except that aminobutyric acid (ABA) was used instead of aminocaproic acid (ACA). Hapten 1 consisted of OLA-HS, and hapten 2 consisted of MQCA.…”
Section: Synthesis Of Coating Antigensmentioning
confidence: 99%
“…For the preparation of hapten 3, 1 mM MQCA was activated with 1.1 mM isobutyl chloroformate and 1.1 mM tributylamine at 4 C for 1 h, added dropwise to 1 mM aminocaproic acid (ACA) dissolved in 0.05 M CB, and stirred for 6 h at 4 C. MQCA-ACA (hapten 3) was obtained following purication (Sundia Med Technology Co., Ltd., Shanghai, China). 30 Hapten 4 was prepared by a similar method to that of hapten 3, except that aminobutyric acid (ABA) was used instead of aminocaproic acid (ACA). Hapten 5 consisted of QCA.…”
Section: Synthesis Of Coating Antigensmentioning
confidence: 99%
“…It has been proved that the sensitivity of the immunoassay could be greatly enhanced with heterology and a desirable spacer arm in the coating antigen. 23,26 In the no. 4 combination, the recognition of II-OVA 1,2 was weakened and the competitiveness of CPAMOZ was enhanced.…”
Section: Optimization Of Elisamentioning
confidence: 99%